Meet “Emma Twin,” Dassault Systèmes’ Avatar Showcasing How Virtual Twins Drive Healthcare Innovation

This initiative aims to raise awareness of the role of virtual twins in accelerating medical research and delivering personalized care

On social media, Emma Twin will document how she, as a virtual twin, helps doctors and researchers better understand diseases and the effects of treatments, without risk to real patients

For 40 years, Dassault Systèmes’ virtual twins have been improving quality of life for patients, citizens and consumers

VELIZY-VILLACOUBLAY, France–(BUSINESS WIRE)–#3DEXPERIENCEDassault Systèmes (Euronext Paris: FR0014003TT8, DSY.PA) today introduced “Emma Twin,” an avatar designed to raise awareness of the key role that virtual twins have in advancing healthcare and the innovations that are shaping the future of medicine.




Through a rich social media program, Emma Twin will share stories explaining how the virtual twin of her body was created from anonymous health data to be used for an infinite number of tests that give doctors and researchers a profound understanding of diseases and the effects of new and improved treatments.

Her social media posts will document her participation in ongoing research and medical innovations including: clinical trials using Medidata solutions; the reaction of her heart to different procedures in the Living Heart project; testing CorNeat Vision’s corneal transplants; epilepsy and Alzheimer’s disease studies in the Living Brain project; wearing the IASO drug administration and monitoring device; and optimizing the home for older adults. They will also highlight: DAMAE Medical’s portable microscope for detecting skin cancer; Dynocardia’s blood pressure monitoring solution; FEops’ cardiac monitoring; LUCID Implants’ customized facial implants; and the VORTHEx radiotherapy simulation experience.

“Through Emma Twin, we will share stories about the impact of virtual twins on healthcare, in an engaging, meaningful way,” said Victoire de Margerie, Vice President, Corporate Equity, Marketing & Communications, Dassault Systèmes. “Our virtual twins have been used to swiftly develop COVID-19 vaccines, optimize surgical procedures, and provide patients with a greater understanding of treatment options. By leveraging our pioneering technology, we can draw attention to major healthcare challenges and demonstrate how the virtual world improves outcomes in real life.”

For 40 years, Dassault Systèmes’ virtual twins – data-enriched, evolving 3D models that replicate reality with scientific accuracy and are used to test and improve performance virtually – have catalyzed sustainable innovations that improve quality of life for consumers, citizens and patients.

Virtual twins accelerate the development of solutions to urgent needs for more precise, preventive healthcare by enabling research and health-related disciplines to model, test and treat a human body as precisely, safely and effectively as other industries can with cars, buildings or airplanes.

Emma Twin is the next act in Dassault Systèmes’ “The Only Progress is Human” initiative, dedicated to healthcare and patient experience. In 2020, the company launched The Only Progress is Human to increase awareness of societal and environmental challenges and inspire the use of virtual worlds to drive sustainable innovations in areas such as urbanization and water conservation.

###

FOR MORE INFORMATION

Meet Emma Twin: https://www.linkedin.com/in/emma-twin/

The Only Progress is Human:

https://www.3ds.com/progress-is-human
https://www.3ds.com/progress-is-human/digital-healthcare

Dassault Systèmes’ 3DEXPERIENCE platform, 3D design software, 3D Digital Mock Up and Product Lifecycle Management (PLM) solutions: http://www.3ds.com

SHARE THIS ON TWITTER

Meet “Emma Twin,” the @Dassault3DS avatar showcasing how #virtualtwins drive healthcare innovation #3DEXPERIENCE: https://www.linkedin.com/in/emma-twin/

Connect with Dassault Systèmes on

Twitter Facebook LinkedIn Youtube

ABOUT DASSAULT SYSTÈMES

Dassault Systèmes, the 3DEXPERIENCE® Company, is a catalyst for human progress. We provide business and people with collaborative virtual environments to imagine sustainable innovations. By creating virtual twin experiences of the real world with our 3DEXPERIENCE platform and applications, our customers can redefine the creation, production and life-cycle-management processes of their offer and thus have a meaningful impact to make the world more sustainable. The beauty of the Experience Economy is that it is a human-centered economy for the benefit of all –consumers, patients and citizens. Dassault Systèmes brings value to more than 300,000 customers of all sizes, in all industries, in more than 150 countries. For more information, visit www.3ds.com

© Dassault Systèmes. All rights reserved. 3DEXPERIENCE, the 3DS logo, the Compass icon, IFWE, 3DEXCITE, 3DVIA, BIOVIA, CATIA, CENTRIC PLM, DELMIA, ENOVIA, GEOVIA, MEDIDATA, NETVIBES, OUTSCALE, SIMULIA and SOLIDWORKS are commercial trademarks or registered trademarks of Dassault Systèmes, a European company (Societas Europaea) incorporated under French law, and registered with the Versailles trade and companies registry under number 322 306 440, or its subsidiaries in the United States and/or other countries.

Contacts

Dassault Systèmes Press Contacts
Corporate / France

Arnaud MALHERBE

[email protected]
+33 (0)1 61 62 87 73

North America

Natasha LEVANTI

[email protected]
+1 (508) 449 8097

EMEA

Virginie BLINDENBERG

[email protected]
+33 (0) 1 61 62 84 21

China

Grace MU

[email protected]
+86 10 6536 2288

India

Kriti ASHOK

[email protected]
+91 9741310607

Japan

Reina MATSUSHITA

[email protected]
+81 3 4321 6650

Korea

Jeemin JEONG

[email protected]
+82 2 3271 6653

AP South

Minming CHEN

[email protected]
+65 6511 7931

Subscribe on LinkedIn

Get the free newsletter

Subscribe to MedicaEx for top news, trends & analysis

We're committed to your privacy. MedicaEx uses the information you provide to us to contact you about our relevant content, products, and services. You may unsubscribe from these communications at any time. For more information, check out our Privacy Policy.

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Businesswire is solely responsible for the content of the above news submissions. If there are any violations of laws, violations of the membership terms of this website, or the risk of infringing on the rights of third parties, businesswire will be solely responsible for legal and damage compensation. Responsibility has nothing to do with MedicaEx.

Are you in?

Subscribe to receive exclusive content and notifications to your inbox

We're committed to your privacy. MedicaEx uses the information you provide to us to contact you about our relevant content, products, and services. You may unsubscribe from these communications at any time. For more information, check out our Privacy Policy.

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.